Rezolute to participate in upcoming investor conferences in september

Redwood city, calif., sept. 06, 2023 (globe newswire) -- rezolute, inc. (nasdaq: rzlt), a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to disrupt current treatment paradigms for devastating metabolic diseases, today announced that nevan charles elam, chief executive officer and founder, will participate in two upcoming investor conferences.
RZLT Ratings Summary
RZLT Quant Ranking